News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Comparing weight loss programs: results are in


Comparing weight loss programs: results are in ... The Lancet

An international study of overweight and obese adults comparing commercial weight loss programs with weight loss plans managed by local doctors or nurses found both groups lost weight, but participants in the commercial program lost significantly more weight.

Participants in the commercial program - in this study Weight Watchers - lost twice as much weight as did those in the standard care group - an average of 5.06kg for those in the commercial program versus 2.25kg for those receiving standard care.

The study, published in The Lancet today, tracked 772 overweight and obese adults in Australia, Germany and the UK, with the Australian arm of the research led by Professor Ian Caterson from the University of Sydney.

"Our research showed Weight Watchers programs work well for those who are overweight and obese, but I was also surprised at how well our doctors do," said Professor Caterson, Director of the Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders.

"This is the first multi-country, randomised, comparative study to show the effectiveness of commercial weight loss programs, as well as weight loss programs administered by primary health carers," Professor Caterson said.

Participants in the commercial program were three times more likely to lose five per cent of their body weight than in the standard care group. As well as losing more weight participants in the commercial program had significantly greater improvements in insulin levels and in ratios of 'good' and 'bad' cholesterol.

Both groups recorded small reductions in blood pressure, though the differences between the two groups were not significant.

Participants in the standard care group reported one appointment per month with their health-care provider, whereas those in the commercial program attended three meetings per month in the UK and Australia, and two meetings per month in Germany.

"The greater level of contact, the more frequent opportunities to be weighed, the peer support and the access to information and resources such as recipes that those in the Weight Watchers program had could have been significant factors," said Professor Caterson.

"We will be carrying out follow-up assessments at 18 and 24 months. Further research will examine the relative cost effectiveness of different treatment approaches," he noted.

Notes to editors Participants were recruited through primary health carers. 377 participants were assigned to the commercial program, with 230 (61%) completing the 12-month assessment. 395 were assigned to standard care, with 214 (54%) completing the 12-month assessment.

Eligible participants were adults 18 years and older with a body-mass index (BMI) of 27-35 kg/m² who had at least one additional risk factor for obesity-related disease.

Participants in the commercial program received free access to weekly community-based Weight Watchers meetings for 12 months, a program based on healthy-eating principles, increased physical activity and group support.

Participants in the standard care group received weight loss advice from a primary care professional at their local general practitioner (GP) practice. Professionals delivering this intervention were provided with, and encouraged to use, national clinical guidelines for treatment, and were made aware of information providing advice about weight loss.

The study received ethics approval from Nottingham Research Ethics Committee (UK), the ethical committee of the Faculty of Medicine of the Technische Universität München (Germany), and the ethics review committee of the Royal Prince Alfred Hospital zone of the Sydney South West Area Health Service (Australia).

The trial received financial support from Weight Watchers, but the research design, implementation and analysis was conducted entirely independently, with funding administered by the Medical Research Council Human Nutrition Research Unit in Cambridge.

ends

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 


Howard Davis: Joel Coen's Monochromatic Macbeth

The Bard of Avon may well be smirking up the sleeves of his lace doublet at the irony of Will Smith's Oscar debacle, but now that the initial furore has dissipated, it's worth revisiting the movie for which Denzel Washington was also nominated. More>>

Howard Davis: Kenneth Branagh’s Black & White Belfast

Branagh has assembled a wonderful cast, including Ciarán Hinds, a gently formidable actor who well deserves his Oscar nomination, and Judi Dench, who steals every scene she’s in. More>>


Howard Davis: Dennis Villeneuve’s Dune - A Brief History

So many elements of Herbert’s novel have since become tropes of popular SciFi that Villeneuve’s film sometimes seems deceptively derivative. What makes all this nonsense essential viewing is his astonishing visual sensibility. More>>


Howard Davis: Jill Trevelyan's Rita Angus

Although Angus has become one of Aotearoa’s best-loved painters, the story of her life remained little known and poorly understood before Jill Trevelyan's acclaimed and revelatory biography, which has been republished by Te Papa press. More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland